Kaya Holdings, Inc. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Kaya Holdings, Inc. (KAYS) has filed its Q1 2024 10-Q report, detailing financial performance and corporate history.</b>

AI Summary

Kaya Holdings, Inc. (KAYS) filed a Quarterly Report (10-Q) with the SEC on May 16, 2024. Kaya Holdings, Inc. filed a 10-Q report for the period ending March 31, 2024. The company was formerly known as Alternative Fuels Americas, Inc. and Alternative Fuels America, Inc. Kaya Holdings, Inc. is classified under Pharmaceutical Preparations (SIC 2834). The filing includes financial data for Q1 2024, comparing it to previous periods. The company's principal business address is in Fort Lauderdale, Florida.

Why It Matters

For investors and stakeholders tracking Kaya Holdings, Inc., this filing contains several important signals. This filing provides investors with the latest quarterly financial snapshot of Kaya Holdings, Inc., crucial for understanding its current operational and financial health. The historical company name changes indicate potential shifts in business focus or strategy over time, which could be relevant for long-term investors.

Risk Assessment

Risk Level: — Kaya Holdings, Inc. shows moderate risk based on this filing. The filing is a standard 10-Q, which is a routine quarterly report and does not inherently contain significant new risks beyond those typically associated with public companies in the pharmaceutical preparations sector.

Analyst Insight

Monitor future filings for specific revenue, net income, and debt-to-equity ratio trends to assess the company's financial trajectory.

Key Numbers

• 2024-03-31 — Report Period End Date (Conformed Period of Report)
• 2024-05-16 — Filing Date (Filed as of Date)
• Q1 2024 — Reporting Quarter (Filing details)

Key Players & Entities

• Kaya Holdings, Inc. (company) — Filer name
• Alternative Fuels Americas, Inc. (company) — Former company name
• Alternative Fuels America, Inc. (company) — Former company name
• Fort Lauderdale (location) — Business address city
• 2834 (SIC code) — Standard Industrial Classification

FAQ

Industry Context

The company operates within the Pharmaceutical Preparations industry, indicated by its SIC code 2834.

Regulatory Implications

As a public company, Kaya Holdings, Inc. is subject to SEC regulations and reporting requirements, including the filing of Form 10-Q for quarterly financial disclosures.

What Investors Should Do

1. Review the full 10-Q document for detailed financial statements and management's discussion and analysis.
2. Analyze year-over-year and sequential changes in financial metrics once available in subsequent filings.
3. Research the company's business activities and market position within the pharmaceutical preparations sector.

Year-Over-Year Comparison

This filing represents the most recent quarterly update for Kaya Holdings, Inc., providing current financial information compared to previous periods.

Key Financial Figures

• $0 — tible notes payable, net of discount of $0 and $0 125,000 125,000 Notes payabl
• $210,000 — mpany concluded the sale of Store 2 for $210,000, less a 6% closing commission and minor
• $75,000 — penses. After these expenses and paying $75,000 to resolve three non-performing store l
• $118,900 — ses in South Oregon, the Company netted $118,900. 9 Kaya Shack Store 3 and Kaya Shack
• $510,000 — cel in Lebanon, Linn County, Oregon for $510,000 on which we intended to construct a Gre
• $500,000 m — Notes "), one of which was secured by a $500,000 mortgage on the Property. CVC released it
• $500,000 — olders, without having to repay CVC the $500,000 Note held by CVC. Additionally, CVC agr
• $270,000 — perty (" Advances "), which amounted to $270,000 pending the sale of the Property. On Fe
• $769,500 — 023 we sold the Property for a price of $769,500, less commissions and customary closing
• $100,000 b — plus interest (including an additional $100,000 borrowed from another lender interest) an
• $302,000,000 — realized net proceeds of approximately $302,000,000. The land is reflected on the balance s
• $516,076 — r ended December 31, 2022 at a value of $516,076. The land was sold in 2023. On Septem
• $1,084,992 — iness. The Company incurred net loss of $1,084,992 for the three months ended March 31, 20
• $67,159 — ended March 31, 2024 and net income of $67,159 for the three months ended March 31, 20
• $8,154,313 — any has a working capital deficiency of $8,154,313 and is totally dependent on its ability

Filing Documents

• kays_10q.htm (10-Q) — 893KB
• ex31_1.htm (EX-31.1) — 14KB
• ex32_1.htm (EX-32.1) — 4KB
• image_001.jpg (GRAPHIC) — 5KB
• image_011.jpg (GRAPHIC) — 17KB
• image_012.jpg (GRAPHIC) — 5KB
• image_013.jpg (GRAPHIC) — 17KB
• image_014.jpg (GRAPHIC) — 62KB
• image_015.jpg (GRAPHIC) — 13KB
• image_016.jpg (GRAPHIC) — 4KB
• image_017.jpg (GRAPHIC) — 40KB
• image_018.jpg (GRAPHIC) — 36KB
• 0001903596-24-000329.txt (&nbsp;) — 5565KB
• kays-20240331.xsd (EX-101.SCH) — 49KB
• kays-20240331_cal.xml (EX-101.CAL) — 53KB
• kays-20240331_def.xml (EX-101.DEF) — 71KB
• kays-20240331_lab.xml (EX-101.LAB) — 265KB
• kays-20240331_pre.xml (EX-101.PRE) — 197KB
• kays_10q_htm.xml (XML) — 991KB

– Financial Information Page

Part I – Financial Information Page Item 1. Consolidated Financial Statements Page Consolidated Balance Sheet 4 Consolidated Statements of Operation 5 Consolidated 6 of Stockholder's deficit for the three month period ended March 31, 2024 and 2023 7 of Comprehensive Income (Loss) for three month period ended March 31, 2024 and 2023 8

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 9 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 29 Item 3. Quantitative and Qualitative Disclosures About Market Risk 41 Item 4. Controls and Procedures 41 Part II Other Information Item 1. Legal Proceedings 43 Item 1A. Risk Factors 44 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 44 Item 3. Defaults Upon Senior Securities 44 Item 4. Mine Safety Disclosures 44 Item 5. Other Information 44 Item 6. Exhibits 44

Signatures

Signatures 45 In this Quarterly Report on Form 10-Q, the terms " KAYS ," " the Company ," " we ," " us " and " our " refer to Kaya Holdings, Inc. and its owned and controlled subsidiaries, unless the context indicates otherwise. Cautionary Note Regarding Forward Looking Statements Information contained in this Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act"). These forward-looking statements are generally identifiable by use of the words "may," "will," "should," "expect," "anticipate," "estimate," "believe," "intend" or "project" or the negative of these words or other variations on these words or comparable terminology. The forward-looking statements herein represent our expectations, beliefs, plans, intentions or strategies concerning future events. Our forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that any projections or other expectations included in any forward-looking statements will come to pass. Moreover, our forward-looking statements are subject to various known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. Except as required by applicable laws, we undertake no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future. Available Information We file annual, quarterly and special reports and other information with the Securities and Exchange Commission ("SEC") that can be obtained from the SEC by telephoning 1-800-SEC-0330. The Company's filings are also available through the SEC's Electronic Data

View Full Filing

View this 10-Q filing on SEC EDGAR